BGNE Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $135.12 = $1351.2
BGNE Charts
BGNE Prices
View the BGNE historical prices.
52WL $132.95
The 52 Week Low is $132.95 set on Tue, Feb 13, 2024.
52WH $270.57
The 52 Week High is $270.57 set on Tue, Apr 18, 2023. The current price, $135.12, is 0% below the 52 Week High.
ATH $426.56
The All-Time High is $426.56 set on Fri, Sep 17, 2021. The current price, $135.12, is 0% below the All Time High.
52 Week Range
BGNE Dividends
BGNE has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
BGNE Profile
BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.
